Search Results
ATLANTIS rucaparib arm: maintenance PARPi following chemotherapy for mUC
Maintenance therapy for patients with advanced urothelial carcinoma
Challenges in the field of PARPi treatment for mCRPC
PARP inhibitors for the treatment of metastic castration-resistant prostate cancer
PARPi olaparib for the targeted treatment of metastatic prostate cancer
2022 GU ASCO Bladder Cancer Highlights
Dr Abhishek Anand | Best Abstracts in Clinical value ASCO GU 2022 Update
